Busse WW - Search Results

1

Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma.

Pavord ID, Deniz Y, Corren J, Casale TB, FitzGerald JM, Izuhara K, Daizadeh N, Ortiz B, Johnson RR, Harel S, Djandji M, Goga L, Crikelair N, Rowe PJ, Busse WW. Pavord ID, et al. Among authors: busse ww. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1213-1220.e2. doi: 10.1016/j.jaip.2022.11.043. Epub 2022 Dec 16. J Allergy Clin Immunol Pract. 2023. PMID: 36535524 Free article. Clinical Trial.

2

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.

Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA. Busse W, et al. J Allergy Clin Immunol. 1999 Jun;103(6):1075-80. doi: 10.1016/s0091-6749(99)70182-x. J Allergy Clin Immunol. 1999. PMID: 10359889 Clinical Trial.

3

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.

Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K; Fluticasone Proprionate Clinical Research Study Group. Busse W, et al. J Allergy Clin Immunol. 2001 Mar;107(3):461-8. doi: 10.1067/mai.2001.114657. J Allergy Clin Immunol. 2001. PMID: 11240946 Clinical Trial.

4

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N. Busse W, et al. J Allergy Clin Immunol. 2001 Aug;108(2):184-90. doi: 10.1067/mai.2001.117880. J Allergy Clin Immunol. 2001. PMID: 11496232 Clinical Trial.

5

Asthma.

Eapen SS, Busse WW. Eapen SS, et al. Among authors: busse ww. Clin Allergy Immunol. 2002;16:325-53. Clin Allergy Immunol. 2002. PMID: 11577547 Review.

6

A comparison of the airway response to segmental antigen bronchoprovocation in atopic asthma and allergic rhinitis.

Becky Kelly EA, Busse WW, Jarjour NN. Becky Kelly EA, et al. Among authors: busse ww. J Allergy Clin Immunol. 2003 Jan;111(1):79-86. doi: 10.1067/mai.2003.28. J Allergy Clin Immunol. 2003. PMID: 12532100

7

6. Asthma.

Lemanske RF Jr, Busse WW. Lemanske RF Jr, et al. Among authors: busse ww. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S502-19. doi: 10.1067/mai.2003.94. J Allergy Clin Immunol. 2003. PMID: 12592297 Free PMC article. Review.

8

Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation.

Liu LY, Swenson CA, Kelly EA, Kita H, Jarjour NN, Busse WW. Liu LY, et al. Among authors: busse ww. J Allergy Clin Immunol. 2003 Apr;111(4):818-25. doi: 10.1067/mai.2003.1346. J Allergy Clin Immunol. 2003. PMID: 12704364

9

Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge.

Liu LY, Jarjour NN, Busse WW, Kelly EA. Liu LY, et al. Among authors: busse ww. J Allergy Clin Immunol. 2003 Sep;112(3):556-62. doi: 10.1016/s0091-6749(03)01798-6. J Allergy Clin Immunol. 2003. PMID: 13679815

10

Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin.

Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW. Sedgwick JB, et al. Among authors: busse ww. J Allergy Clin Immunol. 2004 Sep;114(3):568-74. doi: 10.1016/j.jaci.2004.05.023. J Allergy Clin Immunol. 2004. PMID: 15356558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

584 results

Search Page